🇺🇸 FDA
Pipeline program

LOMUSTINE, 4-L-[131I]iodo-phenylalanine, LOMUSTINE

131I-TLX-101-003

Phase 3 small_molecule active

Quick answer

LOMUSTINE, 4-L-[131I]iodo-phenylalanine, LOMUSTINE for Glioblastoma is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Glioblastoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials